Advertisement
Advertisement
U.S. Markets open in 3 hrs 40 mins
Advertisement
Advertisement
Advertisement
Advertisement

Siemens Aktiengesellschaft (SIEGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
83.04-0.68 (-0.81%)
At close: 03:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close83.72
Open84.13
Bid0.00 x 0
Ask0.00 x 0
Day's Range82.32 - 84.21
52 Week Range67.96 - 88.64
Volume110,801
Avg. Volume153,480
Market Cap132.814B
Beta (5Y Monthly)1.10
PE Ratio (TTM)19.04
EPS (TTM)4.36
Earnings DateN/A
Forward Dividend & Yield2.11 (2.57%)
Ex-Dividend DateFeb 04, 2021
1y Target Est105.27
  • Zacks

    SIEGY vs. GWW: Which Stock Is the Better Value Option?

    SIEGY vs. GWW: Which Stock Is the Better Value Option?

  • Reuters

    Siemens CEO Roland Busch gets 6.94 million euros for 2021

    Siemens Chief Executive Roland Busch picked up 6.94 million euros ($7.86 million) in compensation for the 2021 business year, his first year leading the engineering and technology company, the group's annual report, published on Thursday, showed. The 57-year-old, who took over from long-serving CEO Joe Kaeser in February, saw his compensation, including pension contributions, increase from the 5.05 million euros he received a year earlier as deputy CEO, the annual report said. Kaeser, who led Siemens from 2013, picked up 4.6 million euros for the year to end of Sept. 2021, the report said, down from 9.27 million euros he received a year earlier.

  • Reuters

    Siemens Healthineers bets on Varian to boost growth

    Shares in Siemens Healthineers rose on Wednesday after the German health group said it expected its newly-acquired Varian business to grow faster than other divisions in the coming three years, boosting the group's revenue. Healthineers said revenue at Varian, the U.S. cancer treatment specialist it bought earlier this year in a $16.4 billion deal, should grow between 9% and 12% each year with operating return on sales rising to well over 20% until 2025. The company raised its synergy targets from the Varian takeover to more than 350 million euros ($396 million) by 2025, from a previous goal of 300 million euros.

Advertisement
Advertisement